Evox Therapeutics competitorsClear all

Protalex's top competitors include Biocept and Exosome Diagnostics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Protalex
Protalex
Protalex is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases.
Biocept
Biocept
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Exosome Diagnostics
Exosome Diagnostics
Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.
Founding Date
Founding Date
1999
Founding Date
1993
Founding Date
2008
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Florham Park, US HQ
Locations
San Diego, US HQ
Locations
Waltham, US HQ
Martinsried, DE
Athens, US
Huntsville, US
Mobile, US
Montgomery, US
Opelika, US
see more
Employees
Employees
233% decrease
Employees
878% decrease
Employees
864% decrease
Valuation ($)
Valuation ($)
615.2 k
Valuation ($)
51.7 m
Valuation ($)
N/A
Twitter followers
Twitter followers
240
Twitter followers
2.4 k
Twitter followers
1.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
4
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.1
Average likes per tweet (last 30 days)
3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
90.91%
Percentage of tweets with engagement (last 30 days)
75%
Alexa Website Rank
Alexa Website Rank
463207
Alexa Website Rank
196942
Alexa Website Rank
266272
Employee Rating
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
1.9

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$27.5m (FY, 2020)
Revenue (est.)
N/A
Net income
Net income
($5m) (FY, 2018)
Net income
($17.8m) (FY, 2020)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 15.9m
Total funding raised
$ 112.1m
For sources of this data, please see the company profile

View company profiles

Biocept
HQ
San Diego, US
Employees
87↓ 8% decrease

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.

View company
Exosome Diagnostics
HQ
Waltham, US
Employees
86↓ 4% decrease

Exosome Diagnostics develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.

View company